According to an interview with Nikkei Biotech, Takeda has reduced its staff concerned with regenerative medicine projectds to researchers in charge of T-CiRA, and other researchers have been transferred to the Central Nervous System Disease and other units of Shonan Health Innovation Park. According to the interview, the number of target researchers is estimated to be about 20 people.

Nikkei Biotech news release, August 30, 2018